Company news
Quanterix Corporation news in 2023
Quanterix Corporation's news releases, calls and decks from 2023, newest first.
Quanterix Releases Operating Results for Third Quarter 202
November 5, 2023
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
October 23, 2023
Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection
October 22, 2023
William P. Donnelly Appointed to Quanterix’s Board of Directors
August 20, 2023
Quanterix Appoints Vandana Sriram as Chief Financial Officer
August 8, 2023
Quanterix Releases Operating Results for Second Quarter 2023
August 6, 2023
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
July 19, 2023
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
July 5, 2023
Quanterix Releases Operating Results for First Quarter 2023
May 8, 2023
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
March 5, 2023
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
January 8, 2023
Quanterix Announces Appointment of Brian Blaser to Board of Directors
January 8, 2023
Calls in 2023
Decks in 2023
- Q3 2023 Earnings Presentation
Earnings · 10 slides · Nov 7, 2023
- Q2 2023 Earnings Presentation
Earnings · 12 slides · Aug 8, 2023
- Q1 2023 Earnings Presentation
Earnings · 11 slides · May 9, 2023
- Q4 2022 Earnings Presentation
Earnings · 13 slides · Mar 6, 2023
- Barclays Global Healthcare Conference 2023
Conference · 30 slides · 2023
- J.P. Morgan Healthcare Conference 2023
Conference · 25 slides · January 2023